Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
TScan Therapeutics, Inc. (NASDAQ: TCRX)
TCRX Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
TCRX Stock Analysis
TCRX
PE Ratio:
TCRX
PEG Ratio:
Not Available
TCRX
Forward EPS Growth (12 month):
0.00%
TCRX
PS Ratio:
6.5
TCRX
PSG Ratio:
Not Available
TCRX
Forward Revenue Growth (12 month):
0.00%
TCRX Articles
No data was found